Pembroke Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.4M Sell
506,737
-131,212
-21% -$1.73M 0.96% 31
2026
Q1
$8.79M Sell
637,949
-742,991
-54% -$11.2M 1.27% 26
2025
Q4
$24.9M Sell
1,380,940
-17,946
-1% -$322K 2.57% 17
2025
Q3
$25.9M Sell
1,398,886
-27,610
-2% -$434K 2.57% 16
2025
Q2
$22.8M Sell
1,426,496
-393,132
-22% -$7.01M 2.76% 16
2025
Q1
$35.4M Sell
1,819,628
-172,804
-9% -$3.64M 5.16% 2
2024
Q4
$43.9M Buy
1,992,432
+84,087
+4% +$1.62M 5.47% 2
2024
Q3
$32.1M Buy
1,908,345
+372,619
+24% +$5.53M 4.1% 4
2024
Q2
$18.4M Buy
1,535,726
+786,310
+105% +$8.78M 2.47% 15
2024
Q1
$8.3M Buy
+749,416
New +$7.65M 0.98% 37

Other funds holding CLBT

Pembroke Management's CLBT Position: Q2 2026 in Review

Pembroke Management reduced its Cellebrite (CLBT) stake by 21% in Q2 2026, selling an estimated $1.73M and leaving 506,737 shares worth $7.4M. The position accounts for 0.96% of the portfolio, ranked #31.

Pembroke Management first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $43.9M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Pembroke Management held 506,737 shares of Cellebrite worth $7.4M as of Q2 2026.
  • Pembroke Management sold 131,212 Cellebrite shares in Q2 2026, an estimated $1.73M.
  • Cellebrite made up 0.96% of Pembroke Management's portfolio in Q2 2026, its #31 holding.
  • Pembroke Management first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
  • Pembroke Management's Cellebrite position peaked at $43.9M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.